IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,931,726 | +15.3% | 17,691,000 | +14.6% | 1.34% | +11.0% |
| Q2 2023 | $15,550,040 | +24.1% | 15,432,000 | +24.1% | 1.21% | +27.3% |
| Q1 2023 | $12,527,973 | -28.6% | 12,433,000 | -24.1% | 0.95% | -12.7% |
| Q4 2022 | $17,545,909 | +26.2% | 16,386,000 | +18.6% | 1.09% | +39.9% |
| Q3 2022 | $13,900,000 | +21.3% | 13,818,000 | +25.0% | 0.78% | +12.2% |
| Q2 2022 | $11,459,000 | +151.5% | 11,052,000 | +178.9% | 0.69% | +20.7% |
| Q1 2022 | $4,557,000 | -2.9% | 3,963,000 | -5.7% | 0.58% | +80.3% |
| Q4 2021 | $4,693,000 | -11.0% | 4,201,000 | -5.7% | 0.32% | -20.8% |
| Q3 2021 | $5,272,000 | +2.6% | 4,457,000 | +3.3% | 0.40% | -13.9% |
| Q2 2021 | $5,136,000 | +5.9% | 4,314,000 | -0.9% | 0.47% | -17.3% |
| Q1 2021 | $4,850,000 | +5.7% | 4,355,000 | +6.7% | 0.57% | +18.2% |
| Q4 2020 | $4,589,000 | +15.5% | 4,082,000 | +3.4% | 0.48% | +1.9% |
| Q3 2020 | $3,973,000 | – | 3,946,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 12,388 | $12,458,000 | 0.88% |
| SHENKMAN CAPITAL MANAGEMENT INC | 13,818,000 | $13,900,000 | 0.78% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,510,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,655,000 | $28,803,000 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,334,000 | $12,434,000 | 0.28% |
| CSS LLC/IL | 5,000,000 | $5,024,000 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,700,000 | $22,913,000 | 0.14% |
| Jefferies Group LLC | 7,347,000 | $7,413,724 | 0.06% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 26,000 | $26,000 | 0.04% |
| Calamos Advisors LLC | 7,500,000 | $7,542,000 | 0.03% |